Back to company

VarCT Diagnostics ApS: Financial statements 2022

CVR: 38733567

VarCT Diagnostics ApS (CVR 38733567) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 88,572 and a net result of DKK -1,930,393 compared with DKK -1,746,400 the year before. Equity amounted to DKK 5,065,311. The solvency ratio was 73.6%. The company had 4 employees in the financial year.

Gross Profit
88,572 kr.
Profit/Loss
-1,930,393 kr.
Equity
5,065,311 kr.
Total Assets
6,883,666 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-89 t.-1.9 mio.5.1 mio.4
2021--483 t.-1.7 mio.7 mio.2
2020-1.2 mio.-761 t.8.7 mio.3
2019--2 mio.-3.2 mio.9.5 mio.3
2018--472 t.-1.8 mio.12.7 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on VarCT Diagnostics ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

VarCT Diagnostics ApS: The 2021 annual report is outApr 8, 2022

VarCT Diagnostics ApS has published its annual report for 2021. Gross profit came to DKK -483,495, and the net result was DKK -1,746,400.

Thor Grundtvig Theander joins the board of VarCT Diagnostics ApSApr 1, 2022

As of April 1, 2022, Thor Grundtvig Theander has joined the board of directors of VarCT Diagnostics ApS.

Josef Rainer joins the board of VarCT Diagnostics ApSApr 1, 2022

As of April 1, 2022, Josef Rainer has joined the board of directors of VarCT Diagnostics ApS.

Poul Henrik Bredahl Sorensen joins the board of VarCT Diagnostics ApSApr 1, 2022

As of April 1, 2022, Poul Henrik Bredahl Sorensen has joined the board of directors of VarCT Diagnostics ApS.

About VarCT Diagnostics ApS

VarCT Diagnostics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The company is owned by VAR2 PHARMACEUTICALS ApS and Sitour Management m.b.H.. The company has 4 employees. In 2025, the company reported a gross profit of DKK 176,862 and a net result of DKK -1,961,493 compared with DKK 779,245 the year before. Equity amounted to DKK 2,238,264.

Other financial years